HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 16 filers reported holding HORIZON PHARMA PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,885,000 | +40.0% | 71,312 | +3.5% | 0.00% | +33.3% |
Q4 2018 | $1,346,000 | +2.3% | 68,907 | +2.5% | 0.00% | 0.0% |
Q3 2018 | $1,316,000 | +18.2% | 67,236 | 0.0% | 0.00% | +50.0% |
Q2 2018 | $1,113,000 | +8.2% | 67,236 | -7.2% | 0.00% | 0.0% |
Q1 2018 | $1,029,000 | -4.0% | 72,479 | -1.3% | 0.00% | 0.0% |
Q4 2017 | $1,072,000 | +13.2% | 73,458 | -1.6% | 0.00% | 0.0% |
Q3 2017 | $947,000 | -89.5% | 74,690 | -90.2% | 0.00% | -90.0% |
Q2 2017 | $9,019,000 | -43.2% | 759,811 | -29.3% | 0.02% | -44.4% |
Q1 2017 | $15,889,000 | +3.7% | 1,075,055 | +13.6% | 0.04% | -2.7% |
Q4 2016 | $15,319,000 | -21.3% | 946,764 | -11.8% | 0.04% | 0.0% |
Q3 2016 | $19,459,000 | +1602.4% | 1,073,251 | +1445.9% | 0.04% | +1133.3% |
Q2 2016 | $1,143,000 | +14.5% | 69,426 | +80.6% | 0.00% | +50.0% |
Q1 2015 | $998,000 | +84.8% | 38,447 | -8.3% | 0.00% | +100.0% |
Q4 2014 | $540,000 | +4.9% | 41,925 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $515,000 | – | 41,925 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Scale Management, LLC | 1,710,451 | $59,421,000 | 38.70% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,259,875 | $425,908,000 | 14.19% |
Broadfin Capital, LLC | 4,815,807 | $167,301,000 | 8.99% |
JW Asset Management, LLC | 766,724 | $26,636,000 | 8.10% |
Marble Arch Investments | 1,888,000 | $65,589,000 | 5.65% |
HealthCor Management, L.P. | 3,200,000 | $111,168,000 | 5.60% |
Beach Point Capital Management LP | 794,290 | $27,594,000 | 5.42% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,325,829 | $115,539,000 | 4.52% |
Ratan Capital Management LP | 1,321,300 | $45,902,000 | 4.37% |
Green Owl Capital Management, LLC | 130,000 | $4,516,000 | 3.22% |